Boston, MA, Oct. 23, 2017 -- NewStar Financial, Inc. (“NewStar”) (NASDAQ:NEWS) announced today that it will report financial results for the third quarter of 2017 on Wednesday, November 1, 2017 before the markets open. NewStar will not host an investor conference call to discuss its financial results.
About NewStar Financial, Inc.:
NewStar Financial, Inc. (Nasdaq:NEWS) is an internally-managed commercial finance company with more than $7 billion of assets managed across two complementary business lines — middle market direct lending and asset management. The Company's direct lending activities are focused on meeting the complex financing needs of companies and private investors in the middle markets through specialized lending groups that offer a range of flexible debt financing options to fund working capital, growth strategies, acquisitions and recapitalizations. Through its asset management platforms, NewStar also offers a range of investment products employing credit-oriented strategies focused on middle market loans and liquid, tradeable credit.
NewStar is headquartered in Boston MA and has regional offices in Chicago IL, Darien CT, and New York NY. Please visit our website at www.newstarfin.com for more detailed information.
Robert K. Brown 617.848.2558 [email protected]


Disney Agrees to $10 Million Settlement Over Child Privacy Violations on YouTube
NextEra Energy Stock Rises After Reaffirming Earnings and Dividend Growth Outlook
Royalty Pharma Stock Rises After Acquiring Full Evrysdi Royalty Rights from PTC Therapeutics
Google Accelerates AI Infrastructure With Ironwood TPU Expansion in 2026
Applied Digital Stock Rises on AI Cloud Spinoff Plan and ChronoScale Launch
Baidu Shares Surge as Company Plans Kunlunxin AI Chip Spin-Off and Hong Kong Listing
Vanda Pharmaceuticals Wins FDA Approval for New Motion Sickness Drug After Four Decades
Starlink Plans Satellite Orbit Reconfiguration in 2026 to Boost Space Safety
Nike Stock Rises After CEO Elliott Hill Buys $1 Million in Shares
Lockheed Martin Secures Nearly $500 Million in U.S. and Allied Defense Contracts
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China as Competition Intensifies
SoftBank Completes $41 Billion OpenAI Investment in Historic AI Funding Round
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China, Boosting Access to Wegovy and Mounjaro
Grok AI Faces Global Scrutiny Over Safeguard Failures and Illegal Content on X
Short Interest Rises in Trump Media Stock After $6 Billion Merger Announcement
Samsung Signals Comeback With HBM4 Chips as AI Market Heats Up
Neuralink Plans Automated Brain Implant Surgeries and Mass Production by 2026 



